Head-to-head · WeighScore
MEDGm vs Willow
The verdict
MEDGm takes it — 59.1/100 to 58.2/100, but only just.
MEDGm grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. MEDGm hides every figure behind a sixteen-screen quiz, then prints “your price never increases” beside a rate that goes from $179 to $299 at the first renewal. Willow is close behind and may still be the better fit — see the factor split below.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | MEDGm | Willow |
|---|---|---|
| WeighScore | 59.1/100 | 58.2/100 |
| Grade | C | C |
| Site position | #312 | #342 |
| Semaglutide | $299/mo (standing rate; $179 covers the first month only, after an auto-applied coupon) | $299/mo (starting dose, compounded) |
| Tirzepatide | $399/mo (standing rate; $279 covers the first month only) | $399/mo (starting dose, compounded) |
| Coverage | All 50 states plus Washington, D.C. | Coverage not published |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Site position #312 · C
Strengths
- Names four dispensing pharmacies with street addresses and phone numbers
- States its compounding class — produced in state-licensed 503A or FDA-registered facilities — rather than leaving it unsaid
- Coverage is 50 states plus the District of Columbia and the intake's own state selector agrees with the Terms, which is rarer than it should be
- Refills and shipping are described as included, with no separate shipping line at checkout
- Prices an oral semaglutide lane alongside both injections
Where it loses points
- No price is visible until a sixteen-screen quiz ending in name, email and phone number has been completed
- $179 and $279 are first-month rates produced by an auto-applied coupon; the standing month-to-month rates are $299 and $399
- The treatments FAQ says “your price never increases, even as your dose goes up” on a plan whose price increases at the first renewal
- The twelve-month bundle auto-renews for another full upfront charge of $2,028 or $3,228, billed up to ten days early, and nothing is refundable once taken
- The funnel prints “prescription plan approved” and a 100% success probability before any payment and before a clinician has seen the intake, beside a twenty-minute timer that resets on reload
- Zepbound, Wegovy and Ozempic have cards on the GLP-1 page and all six links lead to the quiz; the post-intake funnel contains none of those names
- No principal place of business is published — only a Delaware state of formation
- No clinician is named and no NPI appears anywhere; the site names professional entities only
Site position #342 · C
Strengths
- Both semaglutide and tirzepatide available
- Compounded GLP-1 access
Where it loses points
- Limited public information on program details
Featured provider
MEDGm
MEDGm scores 59.1/100 (C). MEDGm hides every figure behind a sixteen-screen quiz, then prints “your price never increases” beside a rate that goes from $179 to $299 at the first renewal.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.